Viome Life Sciences has raised $54 million. The funding will bolster the company’s efforts to develop cancer diagnostics and support its separate consumer product division, said CEO Naveen Jain in an interview with GeekWire. Viome’s consumer division offers services to analyze the microbiome, the collection of microbes in the gut and other parts of the body. The Seattle-area company determines the microbiome composition of stool samples through sequencing of the RNA of bacteria and other organisms. The company says that its AI-driven algorithms are able to yield personalized recommendations for diet and supplements.